Cancer therapeutics-related cardiovascular complications. Mechanisms, diagnosis and treatment
E Oikonomou, Φ Anastasiou, G Siasos… - Current …, 2018 - ingentaconnect.com
Background: Chemotherapy regimens have improved prognosis and mortality of patients
with malignant diseases. The development of therapies, however, has widened the …
with malignant diseases. The development of therapies, however, has widened the …
COL1A1: A potential therapeutic target for colorectal cancer expressing wild-type or mutant KRAS
Z Zhang, C Fang, Y Wang, J Zhang… - International …, 2018 - spandidos-publications.com
Colorectal cancer (CRC) treatment primarily relies on chemotherapy along with surgery,
radiotherapy and, more recently, targeted therapy at the late stages. However …
radiotherapy and, more recently, targeted therapy at the late stages. However …
Histopathologic analysis of tamoxifen on epidural fibrosis
Background Epidural fibrosis is a challenging topic in spinal surgery. This phenomenon
constitutes one of the main reasons behind postlaminectomy syndrome or failed back …
constitutes one of the main reasons behind postlaminectomy syndrome or failed back …
[PDF][PDF] 新型抗肿瘤药物致心脏毒性分析
安胜男, 陈喆, 付桂英, 杨珺 - 临床药物治疗杂志, 2021 - lcywzlzz.com
目的分析汇总我国上市的新型抗肿瘤药物导致心脏毒性的类型及发生率, 为临床安全用药提供
依据. 方法检索国家药品监督管理局(NMPA) 官网, 整理可能导致心脏毒性的新型抗肿瘤药物并 …
依据. 方法检索国家药品监督管理局(NMPA) 官网, 整理可能导致心脏毒性的新型抗肿瘤药物并 …
[PDF][PDF] 新型抗肿瘤药物所致心脏毒性及分子机制研究进展
侯欢, 林晨, 张敏, 蒋振伟, 陈蓉 - 中国药学杂志, 2022 - journal11.magtechjournal.com
肿瘤已经成为人类最大致死原因, 发病率与死亡率均呈持续上升趋势. 基于目前恶性肿瘤的治疗,
传统化疗药物已不能完全满足临床需求. 新型抗肿瘤药物靶向特定部位, 一定程度上减少了毒 …
传统化疗药物已不能完全满足临床需求. 新型抗肿瘤药物靶向特定部位, 一定程度上减少了毒 …
[HTML][HTML] CARDIOVASCULAR SIDE EFFECTS OF COLON CANCER THERAPY
K Georgiyeva, P Blake - Sciences of Europe, 2022 - cyberleninka.ru
Colon cancer and cardiovascular diseases present the major two causes of death
worldwide, with colon cancer being the second most prevalent cancer in the United States …
worldwide, with colon cancer being the second most prevalent cancer in the United States …
[HTML][HTML] Mobile Mitral and Aortic Valvular Masses in Patients With Hereditary Hemorrhagic Telangiectasia Receiving Intravenous Bevacizumab
HA Albitar, Y Almodallal, R Nishimura… - Mayo Clinic Proceedings …, 2020 - Elsevier
Bevacizumab is now an emerging treatment option for severe hereditary hemorrhagic
telangiectasia–related bleeding including epistaxis and gastrointestinal tract bleeding. The …
telangiectasia–related bleeding including epistaxis and gastrointestinal tract bleeding. The …
[PDF][PDF] MEDICAL SCIENCES
K Georgiyeva, P Blake - AGRICULTURAL SCIENCES - europe-science.com
Colon cancer and cardiovascular diseases present the major two causes of death
worldwide, with colon cancer being the second most prevalent cancer in the United States …
worldwide, with colon cancer being the second most prevalent cancer in the United States …